Listed pharmas’ secret of profitability increase is financial reduction in SG&A

It was analyzed pharmaceutical companies’ profitability has increased because they reduced selling, general & administrative(SG&A) expenses. In 1 of 3 listed pharmaceutical companies, however, their SG&A expenses which took up about 40% of their sales have still interrupted from increasing profitability.

Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2...